Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Estetrol (E4) in Healthy Female Volunteers
NCT03075956Phase 1Completed
- Sponsor
- Estetra SRL
- Start
- Jan 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of estetrol in menopause and contraception (4 arms), sponsored by Estetra SRL. Primary endpoints: Maximum concentration, Area under the plasma concentration versus time curve from time 0 to 72 hours and 3 more. Started Jan 2017; status: completed.
02
Drugs
estetrol
03
Conditions
menopausecontraception
Beyond the preview
Go deeper on NCT03075956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03075956.